Ignite Creation Date:
2025-12-24 @ 6:41 PM
Ignite Modification Date:
2025-12-28 @ 8:23 PM
Study NCT ID:
NCT00366457
Status:
COMPLETED
Last Update Posted:
2017-05-15
First Post:
2006-08-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer
Sponsor:
Massachusetts General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-08
Start Date Type:
None
Primary Completion Date:
2008-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-07
Completion Date Type:
ACTUAL
First Submit Date:
2006-08-17
First Submit QC Date:
None
Study First Post Date:
2006-08-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-02-14
Results First Submit QC Date:
None
Results First Post Date:
2017-03-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-07
Last Update Post Date:
2017-05-15
Last Update Post Date Type:
ACTUAL